Minitran Dailymed
Generic: nitroglycerin
Go PRO for all pill images
Minitran 5 Mg (italy)
MINITRAN™ 5 mg/24 ore
Cerotti transdermici
AIC n. 027028012
Nitroglicerina
15 cerotti transdermici
superficia di rilascio:
6,7 cm2
MEDA
Venitran 5 Mg (italy)
VENITRAN™ 5MG/24HR
Nitroglycerin
B33211
31-0053-3211-4 / 7100088129
Lot HIJ123K
Exp. 12-2017
Minitran 5 Mg (switzerland)
MINITRAN™ 5
Nitroglycerin
B33233
31-0053-3233-8
Lot III555J
Exp. 12.2018
MEDA
Minitran 5 Mg (belgium)
MINITRAN™ 5 mg
Nitroglycerine 18 mg/pleister
Nitroglycérine 18 mg/dispositif
Nitroglycerin 18 mg/pflaster
30 Pleisters voor transdermaal gebruik
30 Dispositifs transdermiques
30 Transdermale Pflaster
Elke pleister geeft 0,2 mg nitroglycerine af per uur,
overeenkomend met 5 mg per 24 uur.
Chaque dispositif délivre 0,23 mg de nitroglycérine
par heure, Ă©quivalent Ă 5 mg/24 h.
Jedes Pflaster setzt 0,2 mg Nitroglycerin pro
Stunde frei, entsprechend 5 mg in 24 Stunden.
MYLAN
Minitran 5 Mg (mexico)
MINITRAN™
Trinitrato de glicerilo
31-0053-3204-9
Lote: 999991A
Cad: MAR18
Reg. No. 074M91 SSA IV
Parche 18 mg
Cada parche libera 0.2 mg por hora. 5 mg/24 horas
Hecho en EUA por:
3M Drug Delivery Systems
Northridge CA, 91324, EUA
Importado y Distribuido por:
More Pharma Corporation S. de R.L. de C.V.
Blvd. Adolfo Lopez Mateos No. 314 PB, Col.
Tiacopac, C.P. 01049
Deleg. Alvaro ObregĂłn
Ciudad de MĂ©xico, MĂ©xico
More Pharma
Pharmaceutical Company
Consérvese a temperatura ambiente a no mas de
30ÂşC y en lugar seco.
Quantity 5760
Minitran 10 Mg (italy)
MINITRAN™ 10 mg/24 ore
Cerotti transdermici
AIC n. 027028024
Nitroglicerina
15 cerotti transdermici
Superficie di rilascio:
13,3 cm 2
MEDA
Venitran 10 Mg (italy)
VENITRAN™ 10MG/24HR
Nitroglycerin
B33333
31-0053-3333-6
Lot KKK666L
Exp. 12.2018
MEDA
Minitran 10 Mg (belgium)
MINITRAN® 10 mg
Nitroglycerine 36 mg/pleister
Nitroglycérine 36 mg/dispositif
Nitroglycerin 36 mg/pflaster
30 Pleisters voor transdermaal gebruik
30 Dispositifs transdermiques
30 Transdermale Pflaster
Elke pleister geeft 0,4 mg nitroglycerine af per uur,
overeenkomend met 10 mg per 24 uur.
Chaque dispositif délivre 0,4 mg de nitroglycérine
par heure, Ă©quivalent Ă 10mg/24 h.
Jedes Pflaster setzt 0,4 mg Nitroglycerin pro
Stunde frei, entsprechend 10 mg in 24 Stunden.
MYLAN
Minitran 10 (switzerland)
MINITRAN™ 10MG/24HR
Nitroglycerin
B33333
31-0053-3333-6
Lot KKK666L
Exp. 12.2018
MEDA
Minitran 15 Mg (italy)
MINITRAN™ 15 mg/24 ore
Cerotti transdermici
AIC n. 027028036
Nitroglicerina
15 cerotti transdermici
Superficie di rilascio: 20 cm 2
MEDA
Venitran 15 Mg (italy)
VENITRAN™ 15MG/24HR
Nitroglycerin
B33411
31-0053-3411-0 / 7100088860
Lot LMN4560
Exp. 12-2018
MEDA
Minitran 15 Mg (belgium)
MINITRAN™ 15 mg
Nitroglycerine 54 mg/pleister
Nitroglycérine 54 mg/dispositif
Nitroglycerin 54 mg/pflaster
30 Pleisters voor transdermaal gebruik
30 Dispositifs transdermiques
30 Transdermale Pflaster
Elke pleister geeft 0,6 mg nitroglycerine af per uur,
overeenkomend met 15 mg per 24 uur.
Chaque dispositif délivre 0,6 mg de nitroglycérine
par heure, Ă©quivalent Ă 15 mg/24 h.
Jedes Pflaster setzt 0,6 mg Nitroglycerin pro
Stunde frei, entsprechend 15 mg in 24 Stunden.
MYLAN
Minitran 10 Mg (mexico)
MINITRAN™
Trinitrato de Glicerilo
Parche
36 mg
Cada Parche Libera 0.4 mg por hora
10 mg/24 horas
Lote/Lot: XXXXXX
Cad./Exp.: YYYXX
5760
Consérvese a temperatura
ambiente a no más de
30° yen en lugar seco.
Reg. No. 074M91 SSA IV
T M: Marca Registrada/Registered Trademark
More Pharma
Pharmaceutical Company
31-0053-3304-7
Distribuido Por:
More Pharma Corporation S. De R.L.. De C.V.
Av. Ejército Nacional No. 926
Col. Los morales, Seccion Palmas
C.P. 11540, Dele. Miguel Hidalgo,
D.F., MĂ©xico.
Hecho en E.U.A Por:
3M Drug Delivery Systems,
Northridge, Ca 91324 EUA
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
